Jul. 23 at 11:22 AM
$WST Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of
$2.17 up 19.23% YoY
• Reported revenue of
$872.3M up 13.80% YoY
• West Pharmaceutical Services, Inc. expects full-year 2026 net sales of
$3.345 billion to
$3.380 billion and adjusted-diluted EPS of
$8.85 to
$9.05, while third-quarter 2026 adjusted-diluted EPS is
$2.14 to
$2.24.
